Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder

There is increasing interest in the use of cannabis and its major non-intoxicating component cannabidiol (CBD) as a treatment for mental health and neurodevelopmental disorders, such as autism spectrum disorder (ASD). However, before launching large-scale clinical trials, a better understanding of t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuropsychopharmacology
Autori principali: Pretzsch, Charlotte Marie, Freyberg, Jan, Voinescu, Bogdan, Lythgoe, David, Horder, Jamie, Mendez, Maria Andreina, Wichers, Robert, Ajram, Laura, Ivin, Glynis, Heasman, Martin, Edden, Richard A. E., Williams, Steven, Murphy, Declan G. M., Daly, Eileen, McAlonan, Gráinne M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784992/
https://ncbi.nlm.nih.gov/pubmed/30758329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0333-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi